Novogen Gains Health Supplement Patent
CT, 3 December 2003
Limited has been granted the U.S. patent covering health supplements
based on the use of soy isoflavones in tablet or capsule form.
patent has been licensed worldwide, with the exception of Australia
and New Zealand, to Solae LLC of St Louis, Mo. Solae is a joint
venture of the DuPont Company and Bunge.
issuance of the patent is a valuable addition to the patent portfolio
of Novogen in the area of isoflavones and health supplements as
well as an important licensing milestone between the Company and
upon this newly issued patent, Solae has initiated a new patent
infringement suit in the U.S. against both Archer Daniels Midland
Company and Amerfit Inc.
is also listed in Australia. The company manages its international
research and development program using the expertise and clinical
research capabilities of universities and hospitals in the U.S.,
Australia and other key international locations.